The first patent for Actos currently expires in 2011. However, there is very good reason to believe that other Actos patents (which expire later) will provide protection against generic competition for this medication. Takeda Pharmaceuticals has settled several lawsuits about generic versions of Actos. In these settlements, various generic manufacturers will be allowed to start selling generic Actos starting August 17, 2012.
- Actos Information for Consumers
- Actos Information for Healthcare Professionals (includes dosage details)
- Side Effects of Actos (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 21 Aug 2009 • 2 answers
Posted 4 Nov 2009 • 1 answer
Posted 16 Jun 2010 • 1 answer
Posted 14 Jan 2013 • 1 answer
Posted 22 Aug 2015 • 1 answer